Bottom line
FDBCX vs IGIB: the short answer
FDBCX (Federated Hermes Corporate Bond Fund) and IGIB (iShares 5-10 Year Investment Grade Corporate Bond ETF) are both mutual funds.
But IGIB is far broader, holding 2,990 positions to 368 for FDBCX, so beyond the top names it adds exposure FDBCX doesn't have.
IGIB is cheaper at 0.04% vs 1.7% — a difference of $166 a year per $10,000 invested.
Over five years, IGIB returned +1.0% a year vs −0.7% for FDBCX.
Updated Nov 19, 2026
FDBCX vs IGIB side by side
| FDBCX | IGIB | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Federated Hermes | iShares |
| Category | Corporate Bond | Corporate Bond |
| Expense ratio | 1.7% | 0.04% |
| Annual cost per $10k | $170 | $4 |
| 10-yr cost on $10k (prospectus) | $1,856 | $51 |
| Max front load | 0% | None |
| 12b-1 fee | 0.75% | — |
| 1-yr return | +5.1% | +9.6% |
| 5-yr return (annualized) | −0.7% | +1.0% |
| 10-yr return (annualized) | +2.7% | +3.4% |
| Best quarter | — | +10.3% |
| Worst quarter | — | −7.0% |
| Net assets (fund) | $972.9M | $18.2B |
| Number of holdings | 368 | 2,990 |
| Portfolio turnover | 12% | 27% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
FDBCX and IGIB share none of their top holdings.
FDBCX top 10
- Federated Core Trust - High Yield Bond Portfolio — 14.67%
- Jpmorgan Chase & Co — 0.77%
- Nextera Energy Capital — 0.70%
- Dh Europe Finance II — 0.65%
- Wells Fargo & Company — 0.64%
- Anheuser-busch Inbev Wor — 0.59%
- Bank Of America Corp — 0.58%
- Allegion Plc — 0.56%
- Hca Inc — 0.55%
- Leidos Inc — 0.54%
IGIB top 10
- BlackRock Funds III — 11.07%
- Meta Platforms Inc — 0.23%
- Amazon.com Inc — 0.22%
- Anheuser-busch Co/inbev — 0.20%
- Bank Of America Corp — 0.19%
- Bank Of America Corp — 0.19%
- Bank Of America Corp — 0.19%
- Mars Inc — 0.19%
- Pfizer Investment Enter — 0.18%
- Jpmorgan Chase & Co — 0.18%
FAQ
What is the difference between FDBCX and IGIB?
Which is cheaper, FDBCX or IGIB?
Should I own both FDBCX and IGIB?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.